24
Jun
2025

Heron (Shanghai) Pharmaceutical Science & Technology Co., Ltd.

Exhibitor at CPHI & PMEC China 2025
About Us

Founded in 2013, Nanjing Heron Pharmaceutical Science & Technology Company Limited is an innovation-oriented company engaged in the research, development and industrial production of new drugs and first-time generic drugs in China. Active Vitamin D derivatives synthesis and Regulatory Service with Technical Support are the two critical characteristics of Heron Pharma. In 2016, Heron Pharma successfully landed on the NEEQ Stock market (National Equities Exchange and Quotations, Stock Code: 870070). We established a GMP-certified production site for the scale-up and industrial produc...

Read more Show less
Sales Markets
Show more Show less
Categories
more categories Show less
  • CN
  • 2019
    On CPHI since
View company profile
Contact info
  • +86 150 2187 4276
  • Website
  • Room 1903, Building 20, No. 1679 Yuqiao Road, Pudong New Area District,, 201204, Shangai, China
Show contact info Hide contact info
Event information
CPHI & PMEC China 2025
  • 24 Jun 2025 - 26 Jun 2025
  • Shanghai New International Expo Center

Products Featured at CPHI & PMEC China 2025

  • Dexlansoprazole Sodium

    Product Dexlansoprazole Sodium

    produced under GMP conditions, indicated for Gastric ulcer, duodenal ulcer and reflux esophagitis
  • Calcifediol

    Product Calcifediol

    in compliance with the monographs of USP/EP/BP, produced under GMP conditions, indicated for Osteoporosis, Rickets and Osteomalacia.
  • Maxacalcitol

    Product Maxacalcitol

    produced under GMP conditions, indicated for Secondary hyperparathyroidism and Psoriasis
  • Calcitriol

    Product Calcitriol

    Calcitriol (骨化三醇)  in compliance with BP/USP/EP monographs, produced under GMP conditions, indicated for Rickets, Osteoporosis, Hypoparathyroidism, Renal osteodystrophy and Osteomalacia.
  • Alfacalcidol

    Product Alfacalcidol

    Alfacalcidol (阿法骨化醇) is in compliance with the monographs of EP/BP/ChP Grade, produced under GMP conditions and indicated for Osteoporosis, Chronic renal insufficiency, Hypoparathyroidism, Vitamin D-resistant rickets and Osteomalacia.
  • Calcipotriol monohydrate

    Product Calcipotriol monohydrate

    EP/BP Grade, produced under GMP conditions, indicated for Psoriasis Vulgaris.
  • Doxercalciferol

    Product Doxercalciferol

    in compliance with Monograph of USP, produced under GMP conditions and indicated for Secondary hyperparathyroidism
  • Eldecalcitol

    Product Eldecalcitol

    Produced under GMP conditions, indicated for Osteoporosis
  • Paricalcitol

    Product Paricalcitol

     USP grade, produced under GMP conditions and indicated for Secondary hyperparathyroidism
  • Tacalcitol Monohydrate

    Product Tacalcitol Monohydrate

    in compliance with the monographs of EP/JP, produced under GMP conditions and indicated for Psoriasis Vulgaris
  • Bisacodyl

    Product Bisacodyl

    ChP Grade, produced under GMP conditions with China Drug License
  • Bisacodyl Enteric-coated Tablets (5mg)

    Product Bisacodyl Enteric-coated Tablets (5mg)

    8 or16 tablets/blister, GMP production with China's Drug License
  • Diclofenac Sodium Enteric-coated Tablets (25mg)

    Product Diclofenac Sodium Enteric-coated Tablets (25mg)

    24 tablets/blister/box, GMP condition with China Drug License
  • Diclofenac Sodium Eye Drops (5mg/5ml)

    Product Diclofenac Sodium Eye Drops (5mg/5ml)

    1 bottle/box, GMP Condition with China Drug License
  • Diclofenac Sodium Gel (15g : 0.15g)

    Product Diclofenac Sodium Gel (15g : 0.15g)

    1 tube/box, GMP Condition with China Drug License
  • Diclofenac Sodium Sustained Release Capsules (50mg)

    Product Diclofenac Sodium Sustained Release Capsules (50mg)

    10 capsules/blister, GMP Condition with China's Drug License
  • Flucytosine Tablets （0.5 g）

    Product Flucytosine Tablets （0.5 g）

    50 tablets/bottle, GMP condition with China's Drug License
  • Hemodialysis Concentrate Powder

    Product Hemodialysis Concentrate Powder

    All raw materials are at pharmaceutical grade, in compliance with the FDA and EC criteria for Dialysis.

    Type A: NaCl, KCl, CaCl2, MgCl2 and Citric Acid.

    Type B: Sodium Bicarbonate.
    Package: 588g/bag, 700g/bag, 1290g/bag; 720g/drum, 1150g/drum

  • Nonoxynol

    Product Nonoxynol

    ChP/EP grade, produced under GMP conditions with China's Drug License
  • Nonoxynol Gel (4%)

    Product Nonoxynol Gel (4%)

    2 tubes/box, GMP Condition with China's Drug License
  • Nonoxynol Pellicles (50mg)

    Product Nonoxynol Pellicles (50mg)

    10 pieces*3/10 bags/box, GMP conditions with China's Drug License

  • Nonoxynol Suppositories (0.5 g)

    Product Nonoxynol Suppositories (0.5 g)

    6/8 suppositories /blister, GMP Condition, China's Drug License
  • Ornidazole Vaginal Suppositories (0.5 g)

    Product Ornidazole Vaginal Suppositories (0.5 g)

    6/8 suppositories /blister, GMP Condition with China's Drug License

  • Ribavirin Granules (50mg, 100mg)

    Product Ribavirin Granules (50mg, 100mg)

    50mg*20/36 bags/box；100mg*10/20 bags/box. GMP Condition with China's Drug License
  • Tranilast

    Product Tranilast

    ChP/JP grade, produced under GMP conditions with China's Drug License
  • Tranilast Capsules (0.1 g)

    Product Tranilast Capsules (0.1 g)

    24 or 36 capsules/box, GMP conditions with China's Drug License
  • Tranilast Eye Drops (0.5%)

    Product Tranilast Eye Drops (0.5%)

    1 bottle/box, GMP condition with China's Drug License
  • Vanillin

    Product Vanillin

    ChP/EP Grade, produced under GMP conditions with China Drug License
  • Vanillin Tablets (0.2 g)

    Product Vanillin Tablets (0.2 g)

    12 tablets*3 blisters/box, GMP Condition with China's Drug License

  • Vitamin U Aluminum Hydroxide and Magnesium Trisilicate Tablets (Ⅱ)

    Product Vitamin U Aluminum Hydroxide and Magnesium Trisilicate Tablets (Ⅱ)

    Compound Tablets, 24 tablets/blister produced under GMP Conditions with China's Drug License